论文部分内容阅读
目的:对不同批次的三七伤药片进行质量分析,并对药品质量标准进行探讨,为以后临床上三七伤药片的合理使用提供参考。方法:收集不同批次的三七伤药片,按照《中国药典》中收录的三七伤药片质量标准对药品的质量进行分析和统计。结果:目前实施的三七伤药片质量标准共有5种,分别根据这5种标准,对不同批次的药品进行分析,统计结果显示,不同厂家生产的药品执行标准不统一,存在质量控制指标不一致的情况,同时,有部分批次的药品存在不合格的情况,如药片有裂片现象或主要成分柚皮苷含量偏低等。结论:作为骨科常用药品的三七伤药片,在运用于临床前应该受到严格的质量监控,避免在治疗过程中因质量不达标降低药效或使患者产生不良的反应,影响治疗效果、耽误病情。同时,药品质量标准也存在可以改进之处。
OBJECTIVE: To carry out quality analysis on different batches of Panax notoginseng tablets and to probe into the quality standards of the drugs for future reference for the rational use of Panax notoginseng tablets. Methods: We collected different batches of Panax notoginseng tablets and analyzed and counted the quality of the drugs according to the quality standards of Panax notoginseng tablets contained in “Chinese Pharmacopoeia”. Results: At present, there are 5 quality standards for Sanchi Injury tablets. According to these 5 standards, the analysis of different batches of drugs shows that the implementation standards of pharmaceuticals produced by different manufacturers are not uniform and there are inconsistent quality control indicators The same time, there are some batches of drugs there are substandard conditions, such as the phenomenon of lobes tablets or the main component of naringin content is low and so on. Conclusion: As a common orthopedic medicine Sanqi injury tablets, should be subject to strict quality control before use in clinical practice, to avoid ineffective in the course of treatment due to non-compliance to reduce the efficacy or make patients have adverse reactions, affect the treatment effect, delay the disease . At the same time, there are areas where drug quality standards can be improved.